Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Phenotypic variation meets systems biology.
PMID 19664197 · PMC2745761 · Genome biology · 2009 · 8 claims · 8 setups
Cellular differentiation states are constrained by complex networks with substantial positive and negative regulation, challenging the concept of single 'master regulators'
-
Full-text index only
Alternative polyadenylation links RNA processing to iron metabolism in human erythropoiesis.
PMID 41805127 · PMC12972907 · Nucleic acids research · 2026 · 8 claims · 8 setups
CPSF6 facilitates erythropoiesis; its depletion impairs heme synthesis and causes intracellular iron deficiency
-
Full-text index only
Lamin A/C-regulated cysteine catabolic flux modulates stem cell fate through epigenome reprogramming.
PMID 41606307 · PMC12945694 · Nature metabolism · 2026 · 8 claims · 8 setups
Lamin A/C represses cysteine biosynthesis and catabolism in naive mES cells by suppressing CTH and CBS
-
Has reproduction · 50
ZAP targets aberrant mRNA transcripts encoding proteins with defective signal peptides for degradation.
PMID 41820617 · PMC13084044 · The EMBO journal · 2026 · 8 claims · 7 setups
ZAP (ZC3HAV1/PARP13) is a key component of the RAPP quality control pathway
-
Full-text index only
MafB is a conserved transcriptional regulator of macrophage development and functional identity across tissues and species.
PMID 41759510 · PMC7618887 · Immunity · 2026 · 8 claims · 8 setups
MafB is required for full differentiation of bone-marrow-derived macrophages (BMDMs) in vitro and for development of most RTMs in vivo
-
Full-text index only
A Cisplatin-Based Prodrug Inhibits Nucleotide Excision Repair Independently of Chromatin Accessibility to Overcome Resistance.
PMID 42072663 · PMC13113776 · Biomolecules · 2026 · 6 claims · 6 setups
cPVP, a novel Pt(IV) prodrug combining cisplatin with the KDAC inhibitors phenylbutyrate (PhB) and valproic acid (VPA), induces significantly greater cytotoxicity and DNA damage than cisplatin alone